Comparison between rocuronium and succinylcholine for rapid sequence induction: A systematic review and network meta-analysis of randomized clinical trials
Rocuronium has yet an available swift reversal agent: sugammadex [5,6]. [...]succinylcholine may abridge time for oxygen desaturation due to its related muscular fasciculations [7]. [...]apart from contraindications, currently available evidence is not enough to favor either rocuronium or succinylch...
Saved in:
Published in | Journal of clinical anesthesia Vol. 72; p. 110265 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2021
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Rocuronium has yet an available swift reversal agent: sugammadex [5,6]. [...]succinylcholine may abridge time for oxygen desaturation due to its related muscular fasciculations [7]. [...]apart from contraindications, currently available evidence is not enough to favor either rocuronium or succinylcholine for RSI. Study design, screening, data collection, article review.Financial disclosures None.Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. |
---|---|
ISSN: | 0952-8180 1873-4529 |
DOI: | 10.1016/j.jclinane.2021.110265 |